← Leaderboards
Marina Pasca Di Magliano
University Of Michigan At Ann Arbor
$14,782,555
Attributed
$23,041,664
Total exposure
15
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.7M · FY2010–25$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,338,014 · 16
By mechanism
R01$14,199,753 · 7
U54$7,622,486 · 3
U01$5,840,378 · 2
R21$765,032 · 2
T32$675,127 · 1
P30$235,238 · 1
Top collaborators
- Benjamin Allen10 shared
- Howard C Crawford7 shared
- Timothy Louis Frankel7 shared
- Anirban Maitra5 shared
- Filip Bednar4 shared
- Costas Andreas Lyssiotis4 shared
- Stefanie Galban2 shared
- Jason Spence2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Benjamin Allen$7,292,438
- Weiping Zou$38,970,401
- Timothy Louis Frankel$4,183,486
- Diane M Simeone$15,596,624
- Ariella Shikanov$7,267,616
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsFibroblastsPancreasMalignant Neoplasm Of PancreasTumorCellsSignal TransductionNeoplastic CellImmunePathway InteractionsMediatingTumor MicroenvironmentMouse ModelCancer EtiologyCessation Of LifeIn VivoAffectOrganoidsIn VitroMutationEpitheliumTumor GrowthLigandsCarcinogenesis
Grant awards (57)
Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic Cancer$1,547,663
U54 · FY2025 · CA
Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironment$1,128,458
R01 · FY2025 · CA · contact PI
Fibroblast orchestration of the immune response in pancreatic cancer$826,873
U01 · FY2025 · CA · contact PI
Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis$640,945
R01 · FY2025 · CA · contact PI
Investigating GLI transcription factors as regulators of the pancreatic cancer microenvironment$594,235
R01 · FY2025 · CA
Dissecting the role of Notch signaling in the pancreatic cancer microenvironment.$521,831
R01 · FY2025 · CA · contact PI
TBEL Project 1$197,437
U54 · FY2025 · CA · contact PI
The Role of the Tumor Microenvironment in Resistance to Oncogenic KRAS Inhibition in Lung Cancer$182,325
R21 · FY2025 · CA
Signaling and Tumor Microenvironment (STME)$79,888
P30 · FY2025 · CA · contact PI
Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic Cancer$1,390,223
U54 · FY2024 · CA
Fibroblast orchestration of the immune response in pancreatic cancer$786,440
U01 · FY2024 · CA · contact PI
Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis$611,085
R01 · FY2024 · CA · contact PI
Investigating GLI transcription factors as regulators of the pancreatic cancer microenvironment$569,405
R01 · FY2024 · CA
Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironment$536,018
R01 · FY2024 · CA · contact PI
Dissecting the role of Notch signaling in the pancreatic cancer microenvironment.$495,740
R01 · FY2024 · CA · contact PI
TBEL Project 1$248,786
U54 · FY2024 · CA · contact PI
The Role of the Tumor Microenvironment in Resistance to Oncogenic KRAS Inhibition in Lung Cancer$218,790
R21 · FY2024 · CA
Effects of Tissue Block Age on Reliability and Accuracy of In situ Transcriptomics Across Organ Sites using Xenium Technology$199,862
U54 · FY2024 · CA
Signaling and Tumor Microenvironment (STME)$76,837
P30 · FY2024 · CA · contact PI
Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic Cancer$1,600,526
U54 · FY2023 · CA
Fibroblast orchestration of the immune response in pancreatic cancer$829,209
U01 · FY2023 · CA · contact PI
Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis$636,722
R01 · FY2023 · CA · contact PI
Investigating GLI transcription factors as regulators of the pancreatic cancer microenvironment$591,242
R01 · FY2023 · CA
Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironment$552,945
R01 · FY2023 · CA · contact PI
Dissecting the role of Notch signaling in the pancreatic cancer microenvironment.$511,394
R01 · FY2023 · CA · contact PI
TBEL Project 1$509,900
U54 · FY2023 · CA · contact PI
Signaling and Tumor Microenvironment (STME)$78,513
P30 · FY2023 · CA · contact PI
Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic Cancer$1,558,076
U54 · FY2022 · CA
Fibroblast orchestration of the immune response in pancreatic cancer$844,294
U01 · FY2022 · CA · contact PI
Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironment$564,229
R01 · FY2022 · CA · contact PI
Dissecting the role of Notch signaling in the pancreatic cancer microenvironment.$521,831
R01 · FY2022 · CA · contact PI
Establishment and regulation of the immune suppressive microenvironment in pancreatic cancer$492,287
R01 · FY2022 · CA · contact PI
TBEL Project 1$370,013
U54 · FY2022 · CA · contact PI
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer$527,973
U01 · FY2021 · CA · contact PI
Training Program in Organogenesis$349,085
T32 · FY2021 · HD
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer$527,973
U01 · FY2020 · CA
Mechanisms of Pancreatic Inflammation, Tissue Repair and Carcinogenesis$342,097
R01 · FY2020 · CA · contact PI
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer$366,825
R01 · FY2019 · CA
Mechanisms of Pancreatic Inflammation, Tissue Repair and Carcinogenesis$332,022
R01 · FY2019 · CA · contact PI
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer$378,171
R01 · FY2018 · CA
Mechanisms of Pancreatic Inflammation, Tissue Repair and Carcinogenesis$342,479
R01 · FY2018 · CA · contact PI
Training Program in Organogenesis$326,042
T32 · FY2018 · HD
Mechanisms of Pancreatic Inflammation, Tissue Repair and Carcinogenesis$73,036
R01 · FY2018 · CA · contact PI
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer$1,497,616
U01 · FY2017 · CA
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer$378,171
R01 · FY2017 · CA
Mechanisms of Pancreatic Inflammation, Tissue Repair and Carcinogenesis$342,662
R01 · FY2017 · CA · contact PI
Mechanisms of Pancreatic Inflammation, Tissue Repair and Carcinogenesis$72,605
R01 · FY2017 · CA · contact PI
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer$384,048
R01 · FY2016 · CA
Mechanisms of Pancreatic Inflammation, Tissue Repair and Carcinogenesis$342,839
R01 · FY2016 · CA · contact PI
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer$392,629
R01 · FY2015 · CA
Gli Activity in the Pancreas: Inflammation, Tissue Repair and Cancer$293,837
R01 · FY2014 · CA · contact PI
Gli Activity in the Pancreas: Inflammation, Tissue Repair and Cancer$285,024
R01 · FY2013 · CA · contact PI
Novel Hedgehog Receptors As Therapeutic Targets In Pancreatic Cancer$127,168
R21 · FY2013 · CA
Gli Activity in the Pancreas: Inflammation, Tissue Repair and Cancer$303,501
R01 · FY2012 · CA · contact PI
Novel Hedgehog Receptors As Therapeutic Targets In Pancreatic Cancer$236,749
R21 · FY2012 · CA
Gli Activity in the Pancreas: Inflammation, Tissue Repair and Cancer$303,470
R01 · FY2011 · CA · contact PI
Gli Activity in the Pancreas: Inflammation, Tissue Repair and Cancer$297,970
R01 · FY2010 · CA · contact PI